Tirzepatide produced greater mean weight loss and larger reductions in waist circumference than semaglutide over comparable time frames as a clinical confirmation of the dual-agonists potency
This gives you the psychological satisfaction of eating a large, heavy meal, which helps promote physical gastric distension (the stretching of your stomach that signals fullness), all with a fraction of the caloric density
Tirzepatide which targets both GLP-1 and GIP receptors has shown even more dramatic early results: weight loss of 1020 kg and insulin dose reductions exceeding 30% in observational and phase 2 data, with improved CGM time in range
Give yourself time to rest and adjust
The increased c-fos expression occurs in neurons as it is abolished upon co-treatment with tetrodotoxin, a voltage-gated sodium current blocker
This helps regulate blood sugar levels, slows gastric emptying (digestion), and reduces appetite